Business Context and Reporting Period
Company: Deckers Outdoor Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1999
Business Overview: The Company designs, markets, and distributes footwear and apparel under the Teva, Simple, and Ugg brands. Operations are highly seasonal, with Teva sales peaking in Q1/Q2 and Ugg sales peaking in Q4.
Key Financial Metrics
| Metric (Six Months Ended June 30) | 1999 | 1998 |
|---|---|---|
| Net Sales | $69,400,000 | $63,319,000 |
| Gross Profit | $30,979,000 | $26,459,000 |
| Gross Margin | 44.6% | 41.8% |
| Net Earnings | $3,913,000 | $3,159,000 |
| EPS (Diluted) | $0.44 | $0.36 |
| Operating Cash Flow | $14,176,000 | $3,603,000 |
| Cash Balance (End of Period) | $4,819,000 | $5,812,000 |
| Working Capital | $43,070,000 | N/A |
| Long-Term Debt (Net of Current) | $12,379,000 | $15,199,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.6% year-over-year, driven primarily by a 22.0% increase in Teva sales ($59.7M vs $48.9M). This was partially offset by a 31.6% decline in Simple footwear sales due to decreased demand and competition.
- Margin Expansion: Gross margin improved to 44.6% from 41.8%, attributed to better product sourcing, reduced airfreight costs, lower material write-downs, and the exit of the lower-margin components business.
- Expense Management: Selling, general, and administrative (SG&A) expenses rose 12.3% to $22.7M, largely due to approximately $1.0M in special charges related to legal proceedings and corporate restructuring severance.
- Cash Flow: Operating cash flow surged to $14.2M from $3.6M, significantly aided by a $7.2M reduction in inventory levels and a $4.7M decrease in deferred tax assets.
- Debt Reduction: The Company repaid significant debt, reducing current installments of long-term debt from $6.2M to $0.1M and long-term debt from $15.2M to $12.4M.
Guidance, Outlook, and Risks
- Outlook: Management expects full-year 1999 Teva sales to exceed 1998 levels but at a slower growth rate than the first half. Simple sales are expected to decline further, while Ugg sales are projected to increase. SG&A as a percentage of sales is expected to decrease, excluding the $1.0M in special charges.
- Strategic Agreement: On June 7, 1999, the Company signed a new Teva license agreement securing exclusive worldwide rights through 2004 (with renewal options to 2011). Consideration included a $1.0M fee and issuance of 428,743 shares. The agreement includes an option to acquire Teva assets.
- Legal Contingency: A $1.785M judgment was entered against the Company in May 1999 regarding a breach of non-disclosure contract. The Company is appealing and does not anticipate a material adverse effect.
- Trade Risks: Potential exposure to European anti-dumping duties (49.2%) on footwear imported from China/Indonesia. If applicable to certain Teva styles, prior duties could reach $500,000, and future sourcing may need to shift away from China.
- Year 2000 Compliance: The Company is in the final phases of Y2K compliance for enterprise systems, with estimated total costs exceeding $550,000. Risks remain regarding supplier and partner compliance.
Investor Verification Checklist
- Simple Brand Decline: Verify the sustainability of the 31.6% drop in Simple sales and the impact on future inventory levels.
- European Duties: Monitor the resolution of the Dutch Customs opinion regarding anti-dumping duties on Teva styles sourced from China.
- Legal Judgment: Track the appeal status of the $1.785M Montana judgment and any potential increase in damages.
- Debt Covenants: Confirm continued compliance with the tangible net worth covenant under the new $50M revolving credit facility.
- Y2K Readiness: Assess the readiness of key suppliers and logistics partners to ensure no disruption to the critical Q4 Ugg sales season.